[SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED ( AMENDMENT 2 ) New Oriental Education & Technology Group Inc. ( NAME OF ISSUER ) COMMON STOCK (Title of Class of Securities) 647581107 (CUSIP Number) DECEMBER 31,2012 (Date of Event Which Requires Filing of this Statement) X Rule 13d-1 (b) Rule 13d-1 (c) Rule 13d-1]
[SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED ( AMENDMENT 2 ) New Oriental Education & Technology Group Inc. ( NAME OF ISSUER ) COMMON STOCK (Title of Class of Securities) 647581107 (CUSIP Number) DECEMBER 31,2012 (Date of Event Which Requires Filing of this Statement) X Rule 13d-1 (b) Rule 13d-1 (c) Rule 13d-1]
[Ming Yang Comments on Recent Trading Activity Ming Yang wishes to confirm that the management of the Company is unaware of any specific reason for the recent significant increase in the Companys share price and trading volume, other than Chinas recently announced plan to increase installed wind power capacity by 18GW in 2013, representing an increase of 29% from 63GW]
[Ming Yang Comments on Recent Trading Activity Ming Yang wishes to confirm that the management of the Company is unaware of any specific reason for the recent significant increase in the Companys share price and trading volume, other than Chinas recently announced plan to increase installed wind power capacity by 18GW in 2013, representing an increase of 29% from 63GW]
[Contact Information Ida Yu Investor Relations Manager Tel: 86 (21) 6195 9561 ir@htinns.com Email: http://ir.htinns.com China Lodging Group, Limited Announces Preliminary Hotel Operating Results for Fourth Quarter of 2012 Shanghai, China, January 11, 2013 China Lodging Group, Limited (NASDAQ: HTHT) (China Lodging Group or the Company), a leading and fast-growing multi-brand hotel group in China, today announced preliminary hotel]
[Our ref.: PS/BL/B397/ABA2 January 9, 2013 Dear Sirs, We have read Item 4.01(a) of Biostar Pharmaceuticals, Inc’s Form 8-K, which discusses the resignation of Mazars CPA Limited as its independent registered public accounting firm, and we agree with the statements made therein. Yours faithfully, Mazars CPA Limited Mazars CPA Limited Certified Public Accountant CPA Mazars 42ND Floor, Central Plaza, i8]
[Our ref.: PS/BL/B397/ABA2 January 9, 2013 Dear Sirs, We have read Item 4.01(a) of Biostar Pharmaceuticals, Inc’s Form 8-K, which discusses the resignation of Mazars CPA Limited as its independent registered public accounting firm, and we agree with the statements made therein. Yours faithfully, Mazars CPA Limited Mazars CPA Limited Certified Public Accountant CPA Mazars 42ND Floor, Central Plaza, i8]
[SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED ( AMENDMENT 2 ) New Oriental Education & Technology ( NAME OF ISSUER )MMON STOCK (Title of Class of Securities) 647581107 (CUSIP Number) DECEMBER 31,2012 (Date of Event Which Requires Filing of this Statement)]
[SCHEDULE 13G/A (Rule 13d-102) TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED ( AMENDMENT 2 ) New Oriental Education & Technology ( NAME OF ISSUER )MMON STOCK (Title of Class of Securities) 647581107 (CUSIP Number) DECEMBER 31,2012 (Date of Event Which Requires Filing of this Statement)]
[Press Releases Safe Harbor Statement CHANGYOU.COM LIMITED]
